The use of @entity8586 stimulation during cholescintigraphy to calculate the gallbladder ejection fraction has been associated with variable clinical results as a preoperative indicator for chronic @entity7140 and postoperative relief of biliary symptoms. A series of 56 consecutive @entity1 was analyzed to determine the accuracy of a decreased gallbladder ejection fraction as a preoperative indicator for @entity7140 . Each @entity1 had symptoms compatible with @entity253 . Each @entity1 had a decreased gallbladder ejection fraction calculated by cholescintigraphy. The gallbladder ejection fraction was calculated using a 30-minute intravenous infusion of @entity8586 at a dose of 0.02 microg/kg during cholescintigraphy. There was a 100% correlation found in this series of @entity1 between a decreased gallbladder ejection fraction during cholescintigraphy, preoperative symptoms of @entity1085 , and postoperative pathology evidence of acute or chronic @entity2679 . Only 1 @entity1 had less than a complete resolution of her preoperative symptomatology after laparoscopic removal of her gallbladder. This @entity1 had @entity1744 , which was diagnosed postoperatively. Six symptomatic @entity1 with a gallbladder ejection fraction between 35% and 60% were also treated by laparoscopic removal of the gallbladder with complete resolution of their preoperative symptomatology. The use of a 30-minute infusion of @entity8586 at a dose of 0.02 microg/kg to calculate the gallbladder ejection fraction during cholescintigraphy is an accurate test to preoperatively predict @entity7140 and postoperative relief of biliary symptoms. The gallbladder ejection fraction of less than 35% was abnormal. Cholecystectomy may be considered for @entity1 whose gallbladder ejection fractions were calculated to be between 35% and 60% if the @entity1 's symptoms were classical for @entity253 and have been present for 1 year. The use of a 30-minute intravenous infusion of @entity8586 at a dose of 0.02 microg/kg to calculate the gallbladder ejection fraction during cholescintigraphy is an accurate test to preoperatively predict @entity7140 and postoperative relief of biliary symptoms.

Gallbladder ejection fraction: an accurate evaluation of symptomatic XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1085 :: ('MESH:D005705', 'Disease') :: ['gallbladder disease'] @entity8586 :: ('MESH:D002766', 'Chemical') :: ['cholecystokinin'] @entity2679 :: ('MESH:D002764', 'Disease') :: ['cholecystitis'] @entity7140 :: ('MESH:D042101', 'Disease') :: ['acalculous cholecystitis'] @entity253 :: ('MESH:D001660', 'Disease') :: ['biliary disease'] @entity1744 :: ('MESH:D043183', 'Disease') :: ['irritable bowel disease']
@entity1085 :: (MESH:D005705,Disease) :: ['acalculous gallbladder disease']
